Breast cancer resistance protein (Bcrp) an. The testis - An unexpected turn of events

Asian Journal of Andrology

Volumn 15, Issue 4, 2013, Pages 455-460

  Qian, Xiaojing ^a,b   Cheng, Yan Ho ^c   Mruk, Dolores D ^a   Cheng, C Yan ^a  

^a POPULATION COUNCIL   (United States)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c RICHMOND UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

actin filaments; breast cancer resistant protein; ectoplasmic specialisation; effux drug transporter; germ cells; Sertoli cells; spermatids; spermatogenesis; spermiogenesis; testis

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN;

ACTIN FILAMENT; BREAST CANCER; CANCER STAGING; ENDOTHELIUM CELL; GERM CELL; HUMAN; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SERTOLI CELL; SPERMATID; SPERMATOGENESIS; TESTIS;

ATP-BINDING CASSETTE TRANSPORTERS; CELL ADHESION; ENDOTHELIUM, VASCULAR; HUMANS; MALE; NEOPLASM PROTEINS; SERTOLI CELLS; SPERMATIDS; TESTIS;

EID: 84880089590     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2013.24     Document Type: Review

References (63)

1. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 1998; 95: 15665-70.
2. Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E et al. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cacer Inst 1999; 91: 429-33.
3. Natarajan K, Xie Y, Baer MR, Ross DD. Role of breast cancer resistance protein (BCRPi ABCG2) in cancer drug resistance. Biochem Pharmacol 2012; 83: 1084-103.
4. Nakanishi T, Ross DD. Breast cancer resistance protein (BCRPiABCG2): its role in multidrug resistance and regulation of its gene expression. Chin J Cancer 2012; 31: 73-99
5. Muller F, Fromm MF. Transporter-mediated drug-drug interactions. Pharmacogenomics 2011; 12: 1017-37.
6. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152-62.
7. Riordan JR, Ling V. Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J BiolChem 1979; 254: 12701-5.
8. Tamaki A, Ierano C, Szakacs G, Robey RW, Bates SE. The controversial role of ABC transporters in clinical oncology. Easays Biochem 2011; 50: 209-32.
9. Cheng CY, Mruk DD. The blood-testis barrier and its implication inmale contraception. Pharmacol Rev 2012; 64: 16-64.
10. Kis O, Robillard K, Chan GN, Bendayan R. The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters. Trends Pharmacol Sci 2010; 31: 22-35.
11. Ashraf T, Kis O, Banerjee N, Bendayan R. Drug transporters at brain barriers: expression and regulation by neurological disorders. Adv Exp Med Biol 2012; 763: 20-69.
12. Agarwal S, Hartz AM, Elmquist WF, Bauer B. Breast cancer resistance protein and Pglycoprotein in brain cancer: two gatekeepers team up. Curr Pharm Des 2011; 17: 2793-802.
13. Mok KW, Mruk DD, Lie PP, Lui WY, Cheng CY. Adjudin, a potential male contraceptive, exerts its effects locally i. The seminifeorus epithelium of mammalian testes. Reproduction 2011; 141: 571-80.
14. Mruk DD, Silvestrini B, Cheng CY. Anchoring junctions as drug targets: role in contraceptive development. Pharmacol Rev 2008; 60: 146-80.
15. Cheng CY, Lie PP, Wong EW, Mruk DD, Silvestrini B. Adjudin disrupts spermatogenesis vi. The action of some unlikely partners: Eps8, Arp2i3 complex, drebrin E, PAR6 and 14-3-3. Spermatogenesis 2011; 1: 291-7.
16. Cheng CY, Mruk DD, Silvestrini B, Bonanomi M, Wong CH et al. AF-2364 [1-(2, 4-dichlorobenzyl)-1H-indazole-3-carbohydrazide] is a potential male contraceptive: a review of recent data. Contraception 2005; 72: 251-61.
17. Mruk DD, Cheng CY. Delivering non-hormonal contraceptives to men: advances and obstacles. Trends Biotechnol 2008; 26: 90-9.
18. Su L, Mruk DD, Lui WY, Lee WM, Cheng CY. P-glycoprotein regulates blood-testis barrier dynamics via its effects o. The occludinizonula occludens 1 (ZO-1) protein complex mediated by focal adhesion kinase (FAK). Proc Natl Acad Sci USA 2011; 108: 19623-8.
19. Su L, Mruk DD, Lee WM, Cheng CY. Drug transporters and blood-testis barrier function. J Endocrinol 2011; 209: 337-51.
20. Bart J, Hollema H, Groen HJ, de Vries EG, HendrikseNHet al. The distribution of drugefflux pumps, P-gp, BCRP,MRP1and MRP2, i. The normal blood-testis barrier and in primary testicular tumours. Eur J Cancer 2004; 40: 2064-70.
21. Dankers AC, Sweep FC, Pertijs JC, Verweij V, van den Heuvel JJ et al. Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones. Cell Tissue Res 2012; 349: 551-63.
22. Pelletier RM. The blood-testis barrier. The junctional permeability. The proteins an. The lipids. Prog Histochem Cytochem 2011; 46: 49-127.
23. Franca LR, Auharek SA, Hess RA, Dufour JM, Hinton BT. Blood-tissue barriers: morphofunctional and immunological aspects o. The blood-testis and blood- epididymal barriers. Adv Exp Med Biol 2012; 763: 237-59.
24. Cheng CY. Biology and Regulation of Blood-Tissus Barriers. Austin, TX: Landes BioscienceiSpringer Science1Business Media, LLC; 2012. p1-361.
25. Wong EW, Mruk DD, Cheng CY. Biology and regulation of ectoplasmic specialization, an atypical adherens junction type, i. The testis. Biochem Biophys Acta 2008; 1778: 692-708.
26. Wong CH, Cheng CY. The blood-testis barrier: Its biology, regulation and physiological role in spermatogenesis. Curr Topics Dev Biol 2005; 71: 263-96.
27. Setchell BP. Blood-testis barrier, functional and transport proteins and spermatogenesis. Adv Exp Med Biol 2008; 636: 212-33.
28. Setchell B. Blood-testis barrier. In: Knobil E, Neill J, editors. Encyclopedia of Reproduction. New York: Academic Press; 1998. pp375-81.
29. Fawcett D. Ultrastructure and function o. The Sertoli cell. In: Hamilton D, Greep R, editors. Handbook of Physiology. Washington, DC: American Physiological Society; 1975. p21-5.
30. Dym M, Fawcett DW. The blood-testis barrier i. The rat an. The physiological compartmentation o. The seminiferous epithelium. Biol Reprod 1970; 3: 308-26.
31. Fawcett DW, Leak LV, Heidger PM. Electron microscopic observations o. The structural components o. The blood-testis barrier. J Reprod Fertil 1970; (Suppl 10): 105-22.
32. Dym M. The fine structure o. The monkey (Macaca) Sertoli cell and its role in maintainin. The blood-testis barrier. Anat Rec 1973; 175: 639-56.
33. Qian X, Mruk DD, Wong EW, Cheng CY. Breast cancer resistance protein regulates apical ectoplasmic specialization dynamics stage-specifically i. The rat testis. Am J Physiol Endocrinol Metab 2013; 304: E757-69.
34. Su L, Mruk DD, Cheng CY. Drug transporters. The blood-testis barrier and spermatogenesis. J Endocrinol 2011; 208: 207-23.
35. Mruk DD, Su L, Cheng CY. Emerging role for drug transporters a. The blood-testis barrier. Trends Pharmacol Sci 2011; 32: 99-106.
36. Planas JM, Alfaras I, Colom H, Juan ME. The bioavailability and distribution of transresveratrol are constrained by ABC transporters. Arch Biochem Biophys 2012; 527: 67-73.
37. Meyer ZU Schwabedissen HE, Kroemer HK. In vitro and in vivo evidence fo. The importance of breast cancer resistance protein transporters (BCRPiMXRiABCPi ABCG2). Handb Exp Pharmacol 2011; 201: 325-71.
38. Takada T, Suzuki H, Gotoh Y, Sugiyama Y. Regulation o. The cell surface expression of human BCRPiABCG2 b. The phosphorylation state of Akt in polarized cells. Drug Metab Disposit 2005; 33: 905-9.
39. Xie Y, Xu K, Linn DE, Yang XP, Guo Z et al. The 44-kDa Pim-1 kinase phosphorylates BCRPiABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells. J Biol Chem 2008; 283: 3349-56.
40. Enokizono J, Kusuhara H, Ose A, Schinkel AH, Sugiyama Y. Quantitative investigation o. The role of breast cancer resistance protein (BcrpiAbcg2) in limiting brain and testis penetration of xenobiotic compounds. Drug Metab Disposit 2008; 36: 995-1002.
41. Hartz AM, Mahringer A, Miller DS, Bauer B. 17b-Estradiol: a powerful modulator of blood-brain barrier BCRP activity. J Cerebral Blood Flow Metab 2010; 30: 1742-55.
42. Zhang Y, Zhou G, Wang H, Zhang X, Wei F et al. Transcriptional upregulation of breast cancer resistance protein by 17b-estradiol in ERa-positive MCF-7 breast cancer cells. Oncology 2006; 71: 446-55.
43. Wang RS, Yeh S, Tzeng CR, Chang C. Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice. Endocr Rev 2009; 30: 119-32.
44. Carreau S, Hess RA. Oestrogens and spermatogenesis. Philos Trans R Soc Lond B Biol Sci 2010; 365: 1517-35.
45. O'Donnell L, Robertson KM, Jones ME, Simpson ER. Estrogen and spermatogenesis. Endocr Rev 2001; 22: 289-318.
46. Cheng CY, Mruk DD. A local autocrine axis i. The testes that regulates spermatogenesis. Nat Rev Endocrinol 2010; 6: 380-95.
47. Jonker JW, Buitelaar M, Wagenaar E, van der Valk MA, Scheffer GL et al. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci USA 2002; 99: 15649-54.
48. Enokizono J, Kusuhara H, Sugiyama Y. Effect of breast cancer resistance protein (Bcrpi Abcg2) o. The disposition of phytoestrogens. Mol Pharmacol 2007; 72: 967-75.
49. Robaire B. Advancing towards a male contraceptive: a novel approach from an unexpected direction. Trends Pharmacol Sci 2003; 24: 326-8.
50. Melaine N, Lienard MO, Dorval I, Le Goascogne C, Lejeune H et al. Multidrug resistance genes and P-glycoprotein i. The testis o. The rat, mouse, guinea pig, and human. Biol Reprod 2002; 67: 1699-707.
51. Su L, Cheng CY, Mruk DD. Drug transporter, P-glycoprotein (MDR1), is an integrated component o. The mammalian blood-testis barrier. Int J Biochem Cell Biol 2009; 41: 2578-87.
52. Flens MJ, Zaman GJ, van der Valk P, Izquierdo MA, Schroeijers AB et al. Tissue distribution o. The multidrug resistance protein. Am J Pathol 1996; 148: 1237-47.
53. Wijnholds J, Scheffer GL, van der Valk M, van der Valk P, Beijnen JH et al. Multidrug resistance protein 1 protect. The oropharyngeal mucosal layer an. The testicular tubules against drug-induced damage. J Exp Med 1998; 188: 797-808.
54. Cheng CY, Mruk DD. Regulation of spermiogenesis, spermiation and blood-testis barrier dynamics: novel insights from studies on Eps8 and Arp3. Biochem J 2011; 435: 553-62.
55. Cheng CY, Mruk DD. Actin binding proteins and spermatogenesis. Some unexpected findings. Spermatogenesis 2011; 1: 99-104.
56. Vogl AW, Vaid KS, Guttman JA. The Sertoli cell cytoskeleton. Adv Exp Med Biol 2008; 636: 186-211.
57. Russell LD, Peterson RN. Sertoli cell junctions: morphological and functional correlates. Int Rev Cytol 1985; 94: 177-211.
58. Young JS, Vogl AW. Focal adhesion proteins zyxin and vinculin are co-distributed at tubulobulbar complexes. Spermatogenesis 2012; 2: 63-8.
59. Young JS, Guttman JA, Vaid KS, Vogl AW. Cortactin (CTTN), N-WASP (WASL), and clathrin (CLTC) are present at podosome-like tubulobulbar complexes i. The rat testis. Biol Reprod 2009; 80: 153-61.
60. Young JS, Guttman JA, Vaid KS, Vogl AW. Tubulobulbar complexes are intercellular podosome-like structures that internalize intact intercellular junctions during epithelial remodeling events i. The rat testis. Biol Reprod 2009; 80: 162-74.
61. Cheng CY, Mruk DD. An intracellular trafficking pathway i. The seminiferous epithelium regulating spermatogenesis: a biochemical and molecular perspective. Crit Rev Biochem Mol Biol 2009; 44: 245-63.
62. Grandvuinet AS, Vestergaard HT, Rapin N, Steffansen B. Intestinal transporters for endogenic and pharmaceutical organic anions. The challenges of deriving in-vitro kinetic parameters fo. The prediction of clinically relevant drug-drug interactions. J Pharm Pharmacol 2012; 64: 1523-48.
63. Hua WJ, Hua WX, Fang JJ. The role of OATP1B1 and BCRP in pharmacokinetics and DDI of novel statins. Cardiovasc Ther 2011; 30: e234-41.